Morepen Laboratories Management
Management criteria checks 3/4
Morepen Laboratories' CEO is Sushil Suri, appointed in Oct 2000, has a tenure of 23.58 years. total yearly compensation is ₹47.72M, comprised of 91.8% salary and 8.2% bonuses, including company stock and options. directly owns 1.31% of the company’s shares, worth ₹335.35M. The average tenure of the management team and the board of directors is 7.4 years and 18.9 years respectively.
Key information
Sushil Suri
Chief executive officer
₹47.7m
Total compensation
| CEO salary percentage | 91.8% |
| CEO tenure | 23.6yrs |
| CEO ownership | 1.3% |
| Management average tenure | 7.4yrs |
| Board average tenure | 18.9yrs |
Recent management updates
Increases to CEO Compensation Might Be Put On Hold For Now at Morepen Laboratories Limited (NSE:MOREPENLAB)
Sep 22
Increases to CEO Compensation Might Be Put On Hold For Now at Morepen Laboratories Limited (NSE:MOREPENLAB)
Sep 21Recent updates
Morepen Laboratories Limited's (NSE:MOREPENLAB) Popularity With Investors Is Under Threat From Overpricing
Apr 23Morepen Laboratories (NSE:MOREPENLAB) Seems To Use Debt Quite Sensibly
Nov 23Increases to CEO Compensation Might Be Put On Hold For Now at Morepen Laboratories Limited (NSE:MOREPENLAB)
Sep 22Is Morepen Laboratories (NSE:MOREPENLAB) Using Too Much Debt?
Aug 10Increases to CEO Compensation Might Be Put On Hold For Now at Morepen Laboratories Limited (NSE:MOREPENLAB)
Sep 21Should You Be Adding Morepen Laboratories (NSE:MOREPENLAB) To Your Watchlist Today?
Apr 05Do Morepen Laboratories's (NSE:MOREPENLAB) Earnings Warrant Your Attention?
Sep 14Is Morepen Laboratories (NSE:MOREPENLAB) Using Too Much Debt?
May 21Does Morepen Laboratories (NSE:MOREPENLAB) Deserve A Spot On Your Watchlist?
Mar 12Our View On Morepen Laboratories' (NSE:MOREPENLAB) CEO Pay
Feb 22Is Morepen Laboratories Limited's (NSE:MOREPENLAB) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?
Feb 07Morepen Laboratories (NSE:MOREPENLAB) Shareholders Have Enjoyed A 91% Share Price Gain
Jan 21Morepen Laboratories (NSE:MOREPENLAB) Has A Pretty Healthy Balance Sheet
Jan 03
Is There More To The Story Than Morepen Laboratories's (NSE:MOREPENLAB) Earnings Growth?
Dec 16Should You Be Adding Morepen Laboratories (NSE:MOREPENLAB) To Your Watchlist Today?
Nov 28Could The Morepen Laboratories Limited (NSE:MOREPENLAB) Ownership Structure Tell Us Something Useful?
Nov 09Can You Imagine How Morepen Laboratories' (NSE:MOREPENLAB) Shareholders Feel About The 75% Share Price Increase?
Oct 13Morepen Laboratories Limited's (NSE:MOREPENLAB) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
Sep 17Morepen Laboratories Limited's (NSE:MOREPENLAB) Earnings Haven't Escaped The Attention Of Investors
Aug 26Is Now The Time To Put Morepen Laboratories (NSE:MOREPENLAB) On Your Watchlist?
Aug 19We Think Morepen Laboratories (NSE:MOREPENLAB) Can Stay On Top Of Its Debt
Jul 29Update: Morepen Laboratories (NSE:MOREPENLAB) Stock Gained 80% In The Last Five Years
Jul 08CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | ₹761m |
| Sep 30 2023 | n/a | n/a | ₹531m |
| Jun 30 2023 | n/a | n/a | ₹477m |
| Mar 31 2023 | ₹48m | ₹44m | ₹387m |
| Dec 31 2022 | n/a | n/a | ₹428m |
| Sep 30 2022 | n/a | n/a | ₹553m |
| Jun 30 2022 | n/a | n/a | ₹768m |
| Mar 31 2022 | ₹91m | ₹87m | ₹1b |
| Dec 31 2021 | n/a | n/a | ₹1b |
| Sep 30 2021 | n/a | n/a | ₹1b |
| Jun 30 2021 | n/a | n/a | ₹1b |
| Mar 31 2021 | ₹54m | ₹51m | ₹971m |
| Dec 31 2020 | n/a | n/a | ₹814m |
| Sep 30 2020 | n/a | n/a | ₹684m |
| Jun 30 2020 | n/a | n/a | ₹453m |
| Mar 31 2020 | ₹17m | ₹16m | ₹336m |
| Dec 31 2019 | n/a | n/a | ₹331m |
| Sep 30 2019 | n/a | n/a | ₹312m |
| Jun 30 2019 | n/a | n/a | ₹340m |
| Mar 31 2019 | ₹12m | ₹11m | ₹288m |
| Dec 31 2018 | n/a | n/a | ₹252m |
| Sep 30 2018 | n/a | n/a | ₹267m |
| Jun 30 2018 | n/a | n/a | ₹308m |
| Mar 31 2018 | ₹6m | ₹4m | ₹296m |
Compensation vs Market: Sushil's total compensation ($USD571.85K) is above average for companies of similar size in the Indian market ($USD268.08K).
Compensation vs Earnings: Sushil's compensation has been consistent with company performance over the past year.
CEO
Sushil Suri (59 yo)
23.6yrs
Tenure
₹47,718,000
Compensation
Mr. Sushil Suri, B.Sc., FCA has been Managing Director of Morepen Laboratories Limited since October 2000. He has been Chairman of Morepen Laboratories Limited since October 2000 and has been its Director...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & MD | 23.6yrs | ₹47.72m | 1.31% ₹ 335.4m | |
| Whole-Time Director | 9.3yrs | ₹18.12m | 1.08% ₹ 276.0m | |
| Chief Financial Officer | 9.8yrs | ₹9.80m | no data | |
| General Manager of Finance & Accounts (Corporate) | no data | no data | no data | |
| General Manager of Process Engineering & Technology Transfer | no data | no data | no data | |
| Manager of Administration | no data | no data | 0.62% ₹ 159.7m | |
| Company Secretary & Compliance Officer | 5.5yrs | ₹1.84m | no data | |
| Functional Head of Talent Acquisition & HRBP | less than a year | no data | no data | |
| Chief Operating Officer of API | less than a year | no data | no data | |
| Head of Medipath Division | no data | no data | 0.45% ₹ 114.2m | |
| Head of International Business Development | no data | no data | no data | |
| Chief Executive Officer of Consumer Division | no data | no data | 0.60% ₹ 152.7m |
7.4yrs
Average Tenure
46.5yo
Average Age
Experienced Management: MOREPENLAB's management team is seasoned and experienced (7.4 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & MD | 32.3yrs | ₹47.72m | 1.31% ₹ 335.4m | |
| Whole-Time Director | 4.8yrs | ₹18.12m | 1.08% ₹ 276.0m | |
| Independent Non Executive Director | 31.9yrs | ₹465.00k | no data | |
| Independent Non Executive Director | 18.9yrs | ₹575.00k | no data | |
| Independent Non Executive Director | 18.9yrs | ₹625.00k | no data | |
| Independent Director | 4.8yrs | ₹545.00k | no data | |
| Independent Director | 3.9yrs | ₹375.00k | no data |
18.9yrs
Average Tenure
58yo
Average Age
Experienced Board: MOREPENLAB's board of directors are seasoned and experienced ( 18.9 years average tenure).